መነሻ › ቢ-ሴል ሉኬሚያ
በአሜሪካ ለቢ-ሴል ሉኬሚያ ተሳታፊዎችን እየፈለጉ ያሉ ክሊኒካዊ ጥናቶች
ለቢ-ሴል ሉኬሚያ የሚደረጉ 17 ጥናቶች በአሜሪካ ውስጥ ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።
በጣም ብዙ ጥናቶች ያሏቸው ከተሞች
- Houston, TX7 ጥናቶች
- Washington, DC5 ጥናቶች
- Dallas, TX5 ጥናቶች
- Portland, OR4 ጥናቶች
- Columbus, OH4 ጥናቶች
- Spokane, WA3 ጥናቶች
- Chicago, IL3 ጥናቶች
- Denver, CO3 ጥናቶች
- San Diego, CA3 ጥናቶች
- Pittsburgh, PA3 ጥናቶች
- Louisville, KY3 ጥናቶች
- Edison, NJ3 ጥናቶች
- Boston, MA3 ጥናቶች
- New York City, NY3 ጥናቶች
- Philadelphia, PA3 ጥናቶች
- Charlotte, NC3 ጥናቶች
- Clifton, NJ3 ጥናቶች
በክልል
- New Jersey4 ጥናቶች
- New York4 ጥናቶች
- North Carolina5 ጥናቶች
- Ohio7 ጥናቶች
- Oregon4 ጥናቶች
- Pennsylvania5 ጥናቶች
- Texas12 ጥናቶች
- Washington5 ጥናቶች
- ሚኔሶታ3 ጥናቶች
- ማሳቹሴትስ3 ጥናቶች
- ሜሪላንድ5 ጥናቶች
- ኢሊኖይ4 ጥናቶች
- ከንታኪ3 ጥናቶች
- ካሊፎርኒያ7 ጥናቶች
- ካንሳስ3 ጥናቶች
- ኮሎራዶ3 ጥናቶች
- ፍሎሪዳ3 ጥናቶች
በቅርብ ጊዜ የተዘመኑ ጥናቶች
Official study text (English)
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ5 ኦክቶ 2026 · NCT04728893CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ ከ3 እስከ 39 · ሁሉም ጾታዎች · የተሻሻለው በ30 ሴፕቴ 2026 · NCT05442515A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ30 ሴፕቴ 2026 · NCT06542250Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL)
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ ከ18 እስከ 110 · ሁሉም ጾታዎች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT00923507Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart Failure
ተሳታዮችን በመፈለግ ላይደረጃ 4
እድሜ ከ18 እስከ 130 · ሁሉም ጾታዎች · የተሻሻለው በ24 ሴፕቴ 2026 · NCT06651970Chimeric Antigen Receptor Treatment Targeting CD70 (SEVENTY)
ተሳታዮችን በመፈለግ ላይደረጃ 1
እስከ እድሜ 75 · ሁሉም ጾታዎች · የተሻሻለው በ16 ሴፕቴ 2026 · NCT06345027Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ18 እስከ 18 · ሁሉም ጾታዎች · የተሻሻለው በ8 ሴፕቴ 2026 · NCT07509151A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ8 ሴፕቴ 2026 · NCT06564038Trivalent CAR-T Cell in Acute B-Lineage Leukemia (TRICAR-ALL)
ተሳታዮችን በመፈለግ ላይደረጃ 1
12 Months – 25 Years · ሁሉም ጾታዎች · የተሻሻለው በ4 ሴፕቴ 2026 · NCT05010564Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ7 እስከ 25 · ሁሉም ጾታዎች · የተሻሻለው በ19 ኦገስ 2026 · NCT05082519A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ኦገስ 2026 · NCT05254743ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ11 ኦገስ 2026 · NCT07342478A Study of Lonitoclax (ZE50-0134) in Relapsed or Refractory B-cell Malignancies
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ31 ጁላይ 2026 · NCT06708897The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ ከ12 እስከ 95 · ሁሉም ጾታዎች · የተሻሻለው በ15 ኤፕሪ 2026 · NCT04329728A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 66 · ሁሉም ጾታዎች · የተሻሻለው በ17 ማርች 2026 · NCT06859424A Multi-site Study to Evaluate the Persistence of Protective Immunity to Routine Childhood Vaccinations in Participants With B-ALL/Ly Who Have Received Blinatumomab
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ ከ1 እስከ 23 · ሁሉም ጾታዎች · የተሻሻለው በ25 ፌብሩ 2026 · NCT07422337Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ22 ጃንዩ 2026 · NCT06357754ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።